• Porträt
• Chart
• News
• ins Musterdepot
• Realtime
• Wertentwicklungsrechner
• 

Suchtext

Start Datum

 01020304050607080910111213141516171819202122232425262728293031 .  010203040506070809101112 .  20232024

Nachrichtenkategorie

AlleTopthemenMarktberichtePolitikUnternehmensberichteDevisenFondsnachrichten

 

Suchergebnis - CENTESSA PHARMACEUTICALS PLC NAM.-AKT.(SP.ADRS)/1 O.N.

Zeit	Titel
13.05 22:10	dpa-AFX: GNW-Adhoc: Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024
24.04 03:36	dpa-AFX: GNW-Adhoc: Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares
23.04 22:17	dpa-AFX: GNW-Adhoc: Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
22.04 13:00	dpa-AFX: GNW-Adhoc: Centessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024
28.03 21:28	dpa-AFX: GNW-Adhoc: Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023
10.12 18:05	dpa-AFX: GNW-Adhoc: Centessa Pharmaceuticals Announces New Data from an Additional 52-Weeks of Continuous Treatment from Third Year (Part 5) of Ongoing Phase 2a Study of SerpinPC for the Treatment of Hemophilia
13.11 22:05	dpa-AFX: GNW-Adhoc: Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Third Quarter of 2023
25.10 14:00	dpa-AFX: GNW-Adhoc: Centessa Pharmaceuticals Announces Preclinical Data Supporting ORX750's Potential as a Best-in-Class Oral OX2R Agonist for the Treatment of Narcolepsy and Other Sleep-Wake Disorders
14.08 13:00	dpa-AFX: GNW-Adhoc: Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2023
10.07 14:00	dpa-AFX: GNW-Adhoc: Centessa Pharmaceuticals Announces Dosing of First Subject in Registrational PRESent-2 Study Evaluating SerpinPC for the Treatment of Hemophilia B without Inhibitors